By: Neha Sahu
Department of Chemistry School of Basic & Applied Sciences, Lingaya’s Vidyapeeth, Faridabad, Hariyana. Faridabad, Haryana
Heterocyclic compounds, particularly those fused with pyridine rings, have emerged as promising candidates in the search for novel bioactive agents with anti-inflammatory properties. This review highlights recent advances in the discovery and development of fused heterocyclic pyridine compounds as potential anti-inflammatory drugs. The unique structural properties of fused heterocycles contribute to their ability to modulate key inflammatory pathways. By targeting specific molecular targets involved in inflammation, such as cytokines, enzymes, or receptors, these compounds offer new opportunities for therapeutic intervention. Key strategies and methodologies employed in the design and synthesis of fused heterocyclic pyridine compounds are discussed, emphasizing structure-activity relationships and optimization approaches. Furthermore, the biological evaluation of these compounds in relevant models of inflammation provides insights into their pharmacological profiles and potential clinical applications. Notable examples of recently identified fused heterocyclic pyridine compounds with potent anti-inflammatory activities are highlighted, showcasing their diverse chemical structures and mechanisms of action. These compounds hold promise not only as standalone drugs but also as lead compounds for further optimization and development. In conclusion, the exploration of fused heterocyclic pyridine compounds represents a fertile area of research in the quest for innovative anti-inflammatory therapies. The integration of chemical synthesis, biological evaluation, and pharmacological profiling underscores the potential impact of these compounds on future drug discovery efforts targeting inflammatory diseases. Feel free to adjust the content and details based on the specific focus and findings of your research. This abstract provides a concise overview of the scope, significance, and key findings of your work on fused heterocycle compounds of pyridine in the context of anti-inflammatory drug discovery.
Citation:
Refrences:
- Amit Sharma, Sanjay Kumar and Surbhi Sharma, Probiotic: – a versatile compound, world journal of pharmacy and pharmaceutical sciences, 13(2), 2270-2279,2024.
- A. H. Al-Waleedy, E. A. Bakhite, M. S. Abbady, H. H. M. Abdu-Allah. J. Heterocycl. Chem., 57, 2379,2020.
- Dai, M. Zhao, F. Yang, T. Wang, C.Wang, Dyes and Pigments,6(7),108627,2020.
- -J. Li, Y.-F. Zhang, Y.-M. Zhang, Z.-H. Wang, H.-L. Yang, H. Yao, T.-B. Wei, Q. Lin, Dyes and Pigments, 181, article 108563,2020.
- M. EL‐Mahdy, A. M. Elewa, S. W. Huang, H. H. Chou, S.W. Kuo, Adv. Opt. Mater, 8, 2000641,2020.
- Elewa, A. F. M. EL-Mahdy, M. H. Elsayed, M. G. Mohamed, S. -W. Kuo, H.-H. Chou, Chem. Eng. J., 421, 129825,2021.
- Elewa, M. H. Elsayed, A. F. M. EL-Mahdy, C. L. Chang, L. Y. Ting, W. C. Lin, C. Y. Lu,H. H. Chou, Appl. Catal. B, 285, 119802,2021.
- Abdel Aziz, R.M. Ramadan, M.E. Sidqi, M.A. Sayed Structural characterisation of novel mononuclear Schiff base metal complexes, DFT calculations, molecular docking studies, free radical scavenging, DNA binding evaluation and cytotoxic activity Appl. Organomet. Chem., 37 (2023), p. e6954
- Jain, P. Singh (Eds.). Structural and Biological Applications of Schiff Base Metal Complexes (1st ed.). 2023 CRC Press 10.1201/9781003291459.
- A. El-Gammal, A.A. El-Bindary, F.S. Mohamed, G.N. Rezk, M.A. El-Bindary Synthesis, characterization, design, molecular docking, anti COVID-19 activity, DFT calculations of novel Schiff base with some transition metal complexes J. Mol. Liq., 346 (2022), Article 117850
- Peng, B.-B. Liang, W. Liu, Z.-W. Mao What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives Coord. Chem. Rev., 449 (2021), Article 214210
- A. Hrioua, A. Loudiki, A. Farahi, F. Laghrib, M. Bakasse, S. Lahrich, S. Saqrane, M. El Mhammedi Complexation of amoxicillin by transition metals: Physico-chemical and antibacterial activity evaluation Bioelectrochemistry, 142 (2021), Article 107936
- Buldurun, N. Turan, A. Savci, Y. Alan, N. Colak Synthesis, characterization, X-ray diffraction analysis of a tridentate Schiff base ligand and its complexes with Co (II), Fe (II), Pd (II) and Ru (II): Bioactivity studies Iran. J. Chem. Chem. Eng. Research Article, 41 (2022)
- M. Yadav, D. Yadav, D.P. Singh, J.K. Kapoor Pharmaceutical properties of macrocyclic schiff base transition metal complexes: urgent need in today’s world Inorg. Chim. Acta, 121300 (2022)
- M.E. Sidqi, A.A.A. Aziz, A.E. Abolehasan, M.A. Sayed Photochemical processing potential of a novel Schiff base as a fluorescent probe for selective monitoring of Al3+ ions and bioimaging in human cervical cancer HeLa cellS J. Photochem. Photobiol. A Chem., 424 (2022), Article 113616
- M.E. Alkis, K. Buldurun, Y. Alan, N. Turan, A. Altun Electroporation Enhances the Anticancer Effects of Novel Cu (II) and Fe (II) Complexes in Chemotherapy-Resistant Glioblastoma Cancer Cells Chem. Biodivers., 20 (2023), p. e202200710
- K.E. Anwer, Z.K. Hamza, R.M. Ramadan Synthesis, spectroscopic DFT Calculations, Biological Activity, SAR, and Molecular Docking Studies of Novel Bioactive Pyridine Derivatives Sci. Rep., 13 (2023), p. 15598
- A.F. Noureldeen, S.W. Aziz, S.A. Shouman, M.M. Mohamed, Y.M. Attia, R.M. Ramadan, M.M. Elhady Molecular Design, Spectroscopic, DFT, Pharmacological, and Molecular Docking Studies of Novel Ruthenium (III)–Schiff Base Complex: An Inhibitor of Progression in HepG2 Cells Int. J. Environ. Res. Public Health, 19 (2022), p. 13624 19.
- Y. Zhang, A. Pike Pyridones in drug discovery: recent advances Bioorg. Med. Chem. Lett., 38 (2021), Article 127849
- R.M. Ramadan, M.M. Abo-Aly, A.A. Lasheen Molecular structural, vibrational assignments, electronic structure and DFT calculations, and molecular docking of N-benzylideneaniline and N-salicylidene-o-aminoaphenol Schiff bases Inorg. Nano-Metal Chem. (2021), pp. 1-10
